BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas

Journal of Clinical Neuroscience

Volumn 22, Issue 8, 2015, Pages 1250-1253

  Martinoni, Matteo ^a   Marucci, Gianluca ^c   De Biase, Dario ^e   Rubboli, Guido ^a,d   Volpi, Lilia ^a   Riguzzi, Patrizia ^a   Marliani, Federica ^a   Toni, Francesco ^a   Naldi, Ilaria ^b   Bisulli, Francesca ^b,c   Tinuper, Paolo ^b,c   Michelucci, Roberto ^a   Baruzzi, Agostino ^b,c   Tallini, Giovanni ^e   Giulioni, Marco ^a  

^a BELLARIA HOSPITAL   (Italy)

^b IRCCS ISTITUTO DELLE SCIENZE NEUROLOGICHE DI BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d DANISH EPILEPSY CENTRE   (Denmark)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

BRAF V600E mutation; Epilepsy surgery; Focal cortical dysplasia; Gangliogliomas; Pharmacoresistant epilepsy; Seizure outcome

Indexed keywords

B RAF KINASE; CD34 ANTIGEN; ISOCITRATE DEHYDROGENASE 1; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN P53; BRAF PROTEIN, HUMAN;

ADULT; ARTICLE; BRAF GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOCAL EPILEPSY; GENE IDENTIFICATION; GENE MUTATION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NEOCORTICAL LATERAL POSTERIOR TEMPORAL GANGLIOGLIOMA; NEUROSURGERY; POSTERIOR TEMPORAL CORTEX; PRIORITY JOURNAL; TEMPORAL CORTEX; ADOLESCENT; BRAIN NEOPLASMS; CHILD; COMPLICATION; DRUG RESISTANT EPILEPSY; EPILEPSY; EPILEPSY, TEMPORAL LOBE; GANGLIOGLIOMA; GENETICS; MALFORMATION OF CORTICAL DEVELOPMENT GROUP I; MIDDLE AGED; MUTATION; NEOCORTEX; ONSET AGE; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; BRAIN NEOPLASMS; CHILD; DRUG RESISTANT EPILEPSY; EPILEPSY; EPILEPSY, TEMPORAL LOBE; FEMALE; GANGLIOGLIOMA; HUMANS; MALE; MALFORMATIONS OF CORTICAL DEVELOPMENT, GROUP I; MIDDLE AGED; MUTATION; NEOCORTEX; NEUROSURGICAL PROCEDURES; PROGNOSIS; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; SEIZURES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84937518136     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2015.02.016     Document Type: Article

References (28)

1. E. Aronica, S. Leenstra, C.W. van Veelen, and et al. Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery Epilepsy Res 43 2001 179 191
2. I. Blumcke, and O.D. Wiestler Gangliogliomas: an intriguing tumor entity associated with focal epilepsies J Neuropathol Exp Neurol 61 2002 575 584
3. M. Thom, I. Blümcke, and E. Aronica Long-term epilepsy-associated tumors Brain Pathol 22 2012 350 379
4. E. Aronica, S. Redeker, K. Boer, and et al. Inhibitory networks in epilepsy-associated gangliogliomas and in the perilesional epileptic cortex Epilepsy Res 74 2007 33 44
5. M.J. Dougherty, M. Santi, M.S. Brose, and et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas Neuro Oncol 12 2010 621 630
6. G. Schindler, D. Capper, J. Meyer, and et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma Acta Neuropathol 121 2011 397 405
7. G. Marucci, D. de Biase, M. Visani, and et al. Mutant BRAF in low-grade epilepsy-associated tumors and focal cortical dysplasia Ann Clin Transl Neurol 1 2014 130 134
8. C. Peyssonnaux, and A. Eychene The Raf/MEK/ERK pathway: new concepts of activation Biol Cell 93 2001 53 62
9. M. Giulioni, G. Marucci, M. Martinoni, and et al. Seizure outcome in surgically treated drug-resistant mesial temporal lobe epilepsy based on the recent histopathological classifications J Neurosurg 119 2013 37 47
10. D.N. Louis, H. Ohgaki, O.D. Wiestler, and et al. World health organization classification of tumours of the central nervous system 2007 IARC Press Lyon
11. R. Coras, O.J. de Boer, D. Armstrong, and et al. Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias Epilepsia 53 2012 1341 1348
12. T. Forshew, R.G. Tatevossian, A.R. Lawson, and et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas J Pathol 218 2009 172 181
13. M. Babini, M. Giulioni, E. Galassi, and et al. Seizure outcome of surgical treatment of focal epilepsy associated with low-grade tumors in children. Clinical article J Neurosurg Pediatr 11 2013 214 223
14. M. Giulioni, E. Galassi, M. Zucchelli, and et al. Seizure outcome of lesionectomy in glioneuronal tumors associated with epilepsy in children J Neurosurg 102 2005 288 293
15. M. Giulioni, E. Gardella, G. Rubboli, and et al. Lesionectomy in epileptogenic gangliogliomas: seizure outcome and surgical results J Clin Neurosci 13 2006 529 535
16. M. Giulioni, G. Rubboli, G. Marucci, and et al. Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection J Neurosurg 111 2009 1275 1282
17. G. Marucci, M. Martinoni, and M. Giulioni Relationship between focal cortical dysplasia and epilepsy-associated low-grade tumors: an immunohistochemical study APMIS 121 2013 22 29
18. X.R. Ortiz-González, S. Venneti, J.A. Biegel, and et al. Ganglioglioma arising from dysplastic cortex Epilepsia 52 2011 e106 e108
19. A. Tarsi, A.F. Marliani, F. Bartiromo, and et al. MRI findings in low grade tumours associated with focal cortical dysplasia Neuroradiol J 25 2012 639 648
20. C. Chappé, L. Padovani, D. Scavarda, and et al. Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF V600E mutation and expression Brain Pathol 23 2013 574 583
21. K. Jacob, S. Albrecht, C. Sollier, and et al. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours Br J Cancer 101 2009 722 733
22. J.D. Schiffman, J.G. Hodgson, S.R. VandenBerg, and et al. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas Cancer Res 70 2010 512 519
23. G. Bollag, P. Hirth, J. Tsai, and et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma Nature 467 2010 596 599
24. C. Koelsche, A. Wohrer, A. Jeibmann, and et al. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells Acta Neuropathol 125 2013 891 900
25. C. Koelsche, F. Sahm, A. Wöhrer, and et al. BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression Brain Pathol 24 2014 221 229
26. A.S. Pabowo, A.M. Iyer, T.J. Veersema, and et al. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors Brain Pathol 24 2014 52 66
27. A.S. Chi, T.T. Batchelor, D. Yang, and et al. BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults J Clin Oncol 31 2013 e233 6
28. S. Dahiya, D.H. Haydon, D. Alvarado, and et al. BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma Acta Neuropathol 125 2013 901 910